Management of Elevated BUN and Low GFR

Evaluation and Diagnosis

The Kidney International guideline recommends establishing chronicity of kidney dysfunction by reviewing past measurements of GFR, albuminuria/proteinuria, imaging findings, or pathological findings 1
Determine the cause of chronic kidney disease (CKD) using clinical context, personal and family history, medications, physical examination, laboratory measures, imaging, and genetic/pathologic diagnosis 1
Consider kidney biopsy when clinically appropriate to evaluate cause and guide treatment decisions 1
Recognize that BUN elevation may reflect not only decreased GFR but also increased urea reabsorption due to volume depletion, heart failure, or other conditions affecting renal perfusion 2, 3
Assess for disproportionate elevation of BUN relative to creatinine (high BUN/creatinine ratio >15), which may indicate dehydration, heart failure, or catabolic states 3

The Kidney International guideline recommends using creatinine-based estimated GFR (eGFRcr) for initial assessment; if available, use combined creatinine and cystatin C-based eGFR (eGFRcr-cys) for more accurate staging 1
The Diabetes Care guideline recommends initiating ACE inhibitors or angiotensin receptor blockers for patients with hypertension and albuminuria (ACR ≥30 mg/g) 4
Monitor serum creatinine and potassium levels when using ACE inhibitors, angiotensin receptor blockers, or diuretics 4
Recognize that elevated BUN in heart failure may reflect congestion, fluid retention, and cardiac-renal dysfunction 2, 3
Consider that BUN may be a better predictor of outcomes than creatinine or eGFR in acute heart failure 2

The American Journal of Kidney Diseases guideline recommends considering glucocorticoids and immunosuppressive therapy for idiopathic immune complex glomerulonephritis with abnormal kidney function 5
Treat rapidly progressive crescentic glomerulonephritis with high-dose glucocorticoids and cyclophosphamide 5
Consider mycophenolate mofetil plus glucocorticoids for C3 glomerulopathy with moderate-to-severe disease 5

The American Journal of Kidney Diseases guideline recommends not basing the decision to initiate dialysis solely on a specific GFR threshold; instead, consider clinical symptoms, nutritional status, and quality of life 6, 7
Consider initiating dialysis when patients develop uremic symptoms, volume overload unresponsive to diuretics, or metabolic complications despite optimal medical management 6

Test for both urine albumin and GFR in patients at risk for or with CKD 1
Repeat abnormal tests to confirm the presence of CKD 1
Refer patients to a nephrologist if eGFR <30 mL/min/1.73 m² or for uncertainty about kidney disease etiology, difficult management issues, or rapidly progressing kidney disease 4

Avoid assuming chronicity based on a single abnormal eGFR or ACR measurement, as it could result from acute kidney injury 1
Recognize that BUN can be affected by factors other than GFR, including protein intake, catabolic states, gastrointestinal bleeding, and certain medications 3
Be aware that creatinine-based eGFR may be less accurate in patients with unusual muscle mass or nutritional status 6
Consider that some drugs compete with creatinine for tubular secretion, affecting eGFR estimates 6, 7
Understand that dialysis may accelerate the loss of residual kidney function, particularly with hemodialysis-related hypotension 6, 7